DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Motzer RJ, Nosov D, Eisen T. et al.
Tivozanib versus sorafenib as initial targeted therapy for patients with metastatic renal cell carcinoma: results from a phase III trial.
J Clin Oncol 2013;
31: 3791-3799
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.